191 related articles for article (PubMed ID: 3015788)
1. Characterization of three HLA-DR beta genes isolated from an HLA-DR 3/4 insulin-dependent diabetic patient.
Owerbach D; Rich C; Taneja K
Immunogenetics; 1986; 24(1):41-6. PubMed ID: 3015788
[TBL] [Abstract][Full Text] [Related]
2. Polymorphic restriction endonuclease sites linked to the HLA-DR alpha gene: localization and use as genetic markers of insulin-dependent diabetes.
Stetler D; Grumet FC; Erlich HA
Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8100-4. PubMed ID: 2999792
[TBL] [Abstract][Full Text] [Related]
3. A DR3-related DX alpha gene polymorphism strongly associates with insulin-dependent diabetes mellitus.
Hitman GA; Sachs J; Cassell P; Awad J; Bottazzo GF; Tarn AC; Schwartz G; Monson JP; Festenstein H
Immunogenetics; 1986; 23(1):47-51. PubMed ID: 3002976
[TBL] [Abstract][Full Text] [Related]
4. Molecular cloning of a polymorphic DNA endonuclease fragment associates insulin-dependent diabetes mellitus with HLA-DQ.
Michelsen B; Lernmark A
J Clin Invest; 1987 Apr; 79(4):1144-52. PubMed ID: 2881947
[TBL] [Abstract][Full Text] [Related]
5. A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus.
Cohen-Haguenauer O; Robbins E; Massart C; Busson M; Deschamps I; Hors J; Lalouel JM; Dausset J; Cohen D
Proc Natl Acad Sci U S A; 1985 May; 82(10):3335-9. PubMed ID: 2987920
[TBL] [Abstract][Full Text] [Related]
6. In Finland insulin gene region encoded susceptibility to IDDM exerts maximum effect when there is low HLA-DR associated risk. DiMe (Childhood Diabetes in Finland) Study Group.
Metcalfe KA; Hitman GA; Fennessy MJ; McCarthy MI; Tuomilehto J; Tuomilehto-Wolf E
Diabetologia; 1995 Oct; 38(10):1223-9. PubMed ID: 8690176
[TBL] [Abstract][Full Text] [Related]
7. HLA-DR2-associated Dw subtypes correlate with RFLP clusters: most DR2 IDDM patients belong to one of these clusters.
Cohen N; Brautbar C; Font MP; Dausset J; Cohen D
Immunogenetics; 1986; 23(2):84-9. PubMed ID: 3007344
[TBL] [Abstract][Full Text] [Related]
8. Class II HLA-DC beta-chain DNA restriction fragments differentiate among HLA-DR2 individuals in insulin-dependent diabetes and multiple sclerosis.
Cohen D; Cohen O; Marcadet A; Massart C; Lathrop M; Deschamps I; Hors J; Schuller E; Dausset J
Proc Natl Acad Sci U S A; 1984 Mar; 81(6):1774-8. PubMed ID: 6324215
[TBL] [Abstract][Full Text] [Related]
9. Identification of an HLA-DQ beta-chain related genomic sequence associated with insulin-dependent diabetes.
Michelsen B; Kastern W; Lernmark A; Owerbach D
Biomed Biochim Acta; 1985; 44(1):33-6. PubMed ID: 2986612
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR and the 5' insulin gene polymorphism in insulin-dependent diabetes.
Raffel LJ; Vadheim CM; Klein R; Moss SE; Riley WJ; Maclaren NK; Rotter JI
Metabolism; 1991 Dec; 40(12):1244-8. PubMed ID: 1961115
[TBL] [Abstract][Full Text] [Related]
11. Susceptibility to insulin-dependent diabetes defined by restriction enzyme polymorphism of HLA-D region genomic DNA.
Owerbach D; Hägglöf B; Lernmark A; Holmgren G
Diabetes; 1984 Oct; 33(10):958-65. PubMed ID: 6090247
[TBL] [Abstract][Full Text] [Related]
12. HLA-DR antigen frequencies in a North Indian type I diabetic population.
Bhatia E; Mehra NK; Taneja V; Vaidya MC; Ahuja MM
Diabetes; 1985 Jun; 34(6):565-7. PubMed ID: 3891468
[TBL] [Abstract][Full Text] [Related]
13. Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci.
Arnheim N; Strange C; Erlich H
Proc Natl Acad Sci U S A; 1985 Oct; 82(20):6970-4. PubMed ID: 2995996
[TBL] [Abstract][Full Text] [Related]
14. A tumour necrosis factor beta gene polymorphism in relation to monokine secretion and insulin-dependent diabetes mellitus.
Pociot F; Mølvig J; Wogensen L; Worsaae H; Dalbøge H; Baek L; Nerup J
Scand J Immunol; 1991 Jan; 33(1):37-49. PubMed ID: 1996407
[TBL] [Abstract][Full Text] [Related]
15. Only one DQ-beta restriction fragment pattern of each DR specificity is associated with insulin-dependent diabetes.
Böhme J; Carlsson B; Wallin J; Möller E; Persson B; Peterson PA; Rask L
J Immunol; 1986 Aug; 137(3):941-7. PubMed ID: 2424992
[TBL] [Abstract][Full Text] [Related]
16. HLA DR antigens and susceptibility to insulin-dependent diabetes mellitus.
Thomson G
Am J Hum Genet; 1984 Nov; 36(6):1309-17. PubMed ID: 6334991
[TBL] [Abstract][Full Text] [Related]
17. Comparison between HLA-DRB and DQ DNA sequences and classic serological markers as type 1 (insulin-dependent) diabetes mellitus predictive risk markers in the Spanish population.
Vicario JL; Martinez-Laso J; Corell A; Martin-Villa JM; Morales P; Lledo G; Segurado OG; de Juan D; Arnaiz-Villena A
Diabetologia; 1992 May; 35(5):475-81. PubMed ID: 1355747
[TBL] [Abstract][Full Text] [Related]
18. HLA-A, B, C and DR antigen associations in insulin dependent diabetes mellitus (IDDM) in South African Negro (black) and Cape coloured people.
Orren A; Taljaard D; de Toit E
Tissue Antigens; 1985 Nov; 26(5):332-9. PubMed ID: 3867179
[TBL] [Abstract][Full Text] [Related]
19. HLA-A, B, DR antigens and insulin-dependent diabetes in Algerians.
Mercier P; Vallo JJ; Vialettes B; Vague P
Tissue Antigens; 1985 Jul; 26(1):20-4. PubMed ID: 3875911
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQ beta-chain polymorphism linked to myasthenia gravis.
Bell J; Rassenti L; Smoot S; Smith K; Newby C; Hohlfeld R; Toyka K; McDevitt H; Steinman L
Lancet; 1986 May; 1(8489):1058-60. PubMed ID: 2871336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
